We are live on ! Find out more
RMD icon

ResMed
RMD

880 hedge funds and large institutions have $19.4B invested in ResMed in 2026 Q2 according to their latest regulatory filings, with 93 funds opening new positions, 308 increasing their positions, 356 reducing their positions, and 137 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.72% more ownership

Funds ownership: 67.02% → 68.74% (+1.7%)

6% less funds holding

Funds holding: 941 → 880 (-61)

12% less capital invested

Capital invested by funds: $22.2B → $19.4B (-$2.77B)

13% less repeat investments, than reductions

Existing positions increased: 308 | Existing positions reduced: 356

32% less first-time investments, than exits

New positions opened: 93 | Existing positions closed: 137

50% less funds holding in top 10

Funds holding in top 10: 8 → 4 (-4)

57% less call options, than puts

Call options by funds: $67.2M | Put options by funds: $157M

Holders
880
Holders Change
-61
Holders Change %
-6.48%
% of All Funds
10.63%
Holding in Top 10
4
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
93
Increased
308
Reduced
356
Closed
137
Calls
$67.2M
Puts
$157M
Net Calls
-$90M
Net Calls Change
+$53.2M

Top Buyers

Rank Fund Capital Flow
1
First Trust Advisors
First Trust Advisors
Illinois
+$154M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$141M
3
UBS Group
UBS Group
Switzerland
+$117M
4
AQR Capital Management
AQR Capital Management
Connecticut
+$116M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$91.3M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$157M
2
Bank of New York Mellon
Bank of New York Mellon
New York
-$151M
3
Amundi
Amundi
France
-$94.9M
4
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
-$90.9M
5
DAM
Diamant Asset Management
Connecticut
-$83.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
NRG
826
Nemes Rush Group
Michigan
$1.95K – – –
SFG
827
Strive Financial Group
Indiana
$1.95K – – –
T
828
Tidemark
California
$1.95K – – –
VWA
829
Valued Wealth Advisors
Utah
$1.95K – – –
CIA
830
Cape Investment Advisory
Georgia
$1.95K +$2.07K +10 New
CCMI
831
Creative Capital Management Investments
California
$1.95K +$2.07K +10 New
PMFA
832
Plante Moran Financial Advisors
Michigan
$1.95K +$2.07K +10 New
BFPW
833
BOK Financial Private Wealth
Colorado
$1.75K -$24.5K -118 -93%
AAG
834
Armstrong Advisory Group
Massachusetts
$1.75K -$3.73K -18 -67%
SC
835
SouthState Corp
Florida
$1.75K -$1.86K -9 -50%
WSFS
836
Wilmington Savings Fund Society
Delaware
$1.75K +$207 +1 +13%
TFM
837
TFC Financial Management
Massachusetts
$1.56K +$415 +2 +33%
ACA
838
American Capital Advisory
Idaho
$1.56K +$622 +3 +60%
BH
839
Burk Holdings
Oklahoma
$1.56K – – –
WTC
840
WhitTier Trust Company
Nevada
$1.54K -$1.24K -6 -46%
HIA
841
HFM Investment Advisors
New Jersey
$1.36K +$622 +3 +75%
MAM
842
Marquette Asset Management
Minnesota
$1.36K +$1.45K +7 New
SRCM
843
Signature Resources Capital Management
California
$1.36K – – –
NL
844
NVWM LLC
Pennsylvania
$1.36K +$207 +1 +17%
CJ
845
Caitlin John
Michigan
$1.17K -$1.86K -9 -60%
WAG
846
Wilkerson Advisory Group
Missouri
$1.17K -$1.04K -5 -45%
DCM
847
Davis Capital Management
Florida
$1.17K +$1.24K +6 New
HHRDM
848
H&H Retirement Design & Management
Nevada
$1.07K +$1.04K +5 New
TM
849
Torren Management
California
$988 – – –
AA
850
Addison Advisors
Vermont
$975 – – –
32 33
34
35 36

RMD Hedge Fund Activity: Q2 2026 in Review

880 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q2 2026, worth a combined $19.4B — down 12% from $22.2B a quarter earlier.

Sellers outnumbered buyers: 137 funds closed out of RMD and 93 opened new positions — a net loss of 44 holders — while 356 trimmed existing stakes and 308 added.

The largest buyer was First Trust Advisors, adding an estimated $154M. The largest seller was Morgan Stanley, cutting an estimated $157M.

  • 880 institutional investors held ResMed (RMD) as of Q2 2026, down from 941 in Q1 2026.
  • Funds reported $19.4B of ResMed stock for Q2 2026, down 12% quarter-over-quarter.
  • 93 funds opened new ResMed positions in Q2 2026 and 137 closed out, a net change of -44 holders.
  • The largest ResMed buyer in Q2 2026 was First Trust Advisors, an estimated $154M added.
  • The largest ResMed seller in Q2 2026 was Morgan Stanley, an estimated $157M sold.

Based on aggregated 13F filings for Q2 2026.